Chromogenic Factor VIII Inhibitor Bethesda Profile CHF8P
Synonyms |
|
Allscripts (AEHR) Order Name |
Chromogenic Factor VIII Inhibitor Bethesda Profile |
Sunrise Clinical Manager (SCM) Order Name |
Chromogenic Factor VIII Inhibitor Bethesda Prof |
EPIC Order Name |
|
Clinical Info |
Detecting the presence and titer of a specific factor inhibitor directed againstcoagulation factor VIII for patients on emicizumab (Hemlibra) Detecting the presence and titer of an inhibitor directed against factor VIII This test is not useful for detecting the presence of inhibitors directed against other clotting factors and will not detect the presence of lupus anticoagulants. |
Specimen Type |
Blood |
Specimen Volume |
|
Container |
Light Blue Top Tube |
Collection Instructions |
Container Tube: Light Blue Top Tube |
Transport Instructions |
Frozen |
Specimen Stability |
14 Days Frozen |
Methodology |
Chromogenic |
Days Performed |
TAT: 3-5 Days |
Performing Laboratory |
Mayo Medical Laboratories |
CPT |
85130 |
PDM |
245700 |
Result InterpretationCHROMOGENIC Factor VIII Activity Assay Adults: 55.0-200.0% Normal, full-term newborn infants or healthy premature infants usually have normal or elevated factor VIII. BETHESDA TITER < or =0.5 Bethesda Units |
|
Forms |
|
